Elevated risk of prostate cancer among men with Lynch syndrome. - Wikidata - wikimedia - TriplyDB

Elevated risk of prostate cancer among men with Lynch syndrome.

Elevated risk of prostate cancer among men with Lynch syndrome.

http://www.wikidata.org/entity/Q36810712

about

Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer Mutational landscape of candidate genes in familial prostate cancer The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.The evolution of colorectal cancer genetics-Part 2: clinical implications and applications Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.Prostate cancer incidence in males with Lynch syndrome Prostate cancer risk prediction based on complete prostate cancer family history.DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry Screening for familial and hereditary prostate cancer.Frequent mismatch-repair defects link prostate cancer to Lynch syndrome A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes Syndrome-Associated Tumors by Organ System.HOXB13 and other high penetrant genes for prostate cancer.History, genetics, and strategies for cancer prevention in Lynch syndrome.Criteria and prediction models for mismatch repair gene mutations: a review.The genomic evolution of human prostate cancer.Germline genetic variants in men with prostate cancer and one or more additional cancers.Mismatch repair deficiency testing in clinical practice.Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome.The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms.Inherited Predisposition to Prostate Cancer: From Gene Discovery to Clinical Impact.Is prostate cancer a Lynch syndrome cancer?Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types.MSH2 Loss in Primary Prostate Cancer.Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.Tumor development in Japanese patients with Lynch syndrome.Prostate cancer in the era of "Omic" medicine: recognizing the importance of DNA damage repair pathways.Male Oncology Research and Education program for men at high risk for prostate cancer.Precision medicine applications in prostate cancer.

P2860

Q26797255-4C82B7C8-D312-41D0-AD66-D2DE4BE168BF Q34079517-11B41F03-8C7B-451F-8342-A40987C106A4 Q34081267-26AFEA18-BD7A-47F8-8AF2-1999BA987471 Q34234950-95F3B73C-58E1-4CE7-BA0B-45BB059D9940 Q34478988-A0354DC2-0621-4AB7-B13C-106152EDBBA0 Q34901622-D2C38DD8-31F6-459D-BEA2-E95A1A5A8E34 Q34944738-149072CD-C2ED-4AF8-B0B4-728FF8E7EE0D Q34956579-1D8781E9-E121-4155-861F-C5ADD14893A2 Q35085756-50A2FA53-5506-4ABC-A08B-91F8D9DE01D5 Q35861576-24D47FC7-2A48-463E-820C-402A4A4D28DE Q35969934-AA735E86-ADBD-46B9-93F9-68B69D3A6841 Q36085161-071BEB42-0BF2-4888-BB5E-931FA4706C08 Q36416282-2A3E914F-9D9A-4451-8277-23A922FB7496 Q37032662-71830A60-AB8D-4866-9EDE-D99AFB6BB42C Q37113171-DF8E05D2-4F30-45F0-8D5F-10A67EA39B16 Q37716875-C5C1BB7C-0840-4AAC-95A1-FDE37BE1CEAB Q38129858-11A3BFB0-0589-4A15-A6FD-C9FE16CA4E34 Q38540636-1B03ECD3-8582-49FF-B72E-CE10323F1F15 Q38705089-22CBB9C7-6D15-4933-BB8B-350BC42BD65B Q38741029-A64F2D17-A6CC-4C7F-91AA-C57395159232 Q38895750-206DE8CD-7673-4F55-9AB0-F123B5DA636F Q39141778-FC0A11C0-3527-4B5F-A061-3DB771357E84 Q39337246-67A7FE36-90CD-4807-AD6C-25D1087C1BEC Q40625913-F82D37D4-17BF-470C-8AEA-432D4D0C746F Q41101605-5A7A787B-D950-44AA-BFCB-B9EEB1681F52 Q41112357-2F1CD0A0-D038-4FA5-AA6E-22C31782DAB2 Q41852329-1FCDD22E-3415-438A-95F3-E0DEE9F29F21 Q46083971-8E43C51D-8DBF-42B2-A173-624DCDA269B1 Q47729288-0D5FA8F4-112F-4A5E-A8C1-E495AD023964 Q47976701-ABF98896-869E-4463-8353-D0FE6A4B6D95 Q51063696-7A069EE6-9AE9-4AF6-9922-AC976462ED06 Q52566012-65ED1A4F-F50A-45CF-BBED-1025B7DA2B58 Q52577954-AD0A7B8A-1150-4C45-88E8-743CCDBBD360 Q55172706-DB9BE1AE-17C6-4086-8849-7781BF48E937 Q55249860-CDE0E195-4CF1-4EFB-A388-36B4C206938B Q55439000-396FAE6B-6BC6-419D-B21C-D2CB604A159F

P2860

Elevated risk of prostate cancer among men with Lynch syndrome.

http://www.wikidata.org/entity/Q36810712

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Elevated risk of prostate cancer among men with Lynch syndrome.

@ast

Elevated risk of prostate cancer among men with Lynch syndrome.

@en

type

label

Elevated risk of prostate cancer among men with Lynch syndrome.

@ast

Elevated risk of prostate cancer among men with Lynch syndrome.

@en

prefLabel

Elevated risk of prostate cancer among men with Lynch syndrome.

@ast

Elevated risk of prostate cancer among men with Lynch syndrome.

@en

P1433

Q36810712-AB522A27-C4E0-46F8-8390-B017EDF75FDC

P1476

Q36810712-4D060B40-70CF-4C05-ADDE-BBC4746A04BC

P2093

Q36810712-09A1D21E-95F4-43C3-933A-4F08DCE5C10C

Q36810712-271AA148-3CF8-4AEF-9F41-647D1FBAB72E

Q36810712-3FEC290C-511C-4697-9758-620A12106B37

Q36810712-52135554-39F8-491C-9778-0FF25E8F1C81

Q36810712-5F0FD07D-7E18-4731-9CCE-BF0A829301FB

Q36810712-8384F09C-E3B3-485E-9C91-E5CD5C9C20B7

Q36810712-A517B41E-4350-40A7-AF37-6D398760A8C2

Q36810712-AE5E7D45-9853-4944-94CE-46ACBB152944

Q36810712-CD0CE139-D69A-40B2-A056-FE2FFC7A706B

P2860

Q36810712-00130734-40DF-4B54-B768-33F908EB1ED6

Q36810712-1A55F93A-7EE3-4129-A258-7328D338FE1A

Q36810712-2068EAC0-63B4-4B33-8510-EEF3805B4D7B

Q36810712-2C341A65-55CE-414B-82A0-74736EE18BCD

Q36810712-3D12DC24-E6D1-43B7-AE1C-125449F7BB90

Q36810712-44E3E98A-8C88-4EEB-B7DD-CA5B5978100B

Q36810712-53CE464D-8D3D-49F8-95D9-9FDE57AC0BB8

Q36810712-651280A7-8C87-4BFB-9E8B-0AEB4669C8A9

Q36810712-6C310B52-71E5-4184-8ED3-D4A9B2D2179F

Q36810712-7C02BFD1-B56F-48CE-A6B0-D0656D5DC71D

P304

Q36810712-A5994CEA-7A08-4B98-B520-1321B7F4ED1E

P31

Q36810712-8542555E-B211-4BF3-8DD2-783D511732F7

P356

Q36810712-E978C79A-D241-413E-8E1F-A2ABF1C7A144

P407

Q36810712-B1F6B9F6-B3A9-45FF-9ECC-75139D8B3612

P433

Q36810712-B7ED79E7-3F8E-455C-B6C1-7867D8E5A118

P478

Q36810712-59919918-034C-4939-9D6C-844CD24317BE

P577

Q36810712-CE1765B7-8D17-42E3-B9CA-494A1AA37129

P5875

Q36810712-E40B37D5-E5B4-4E77-B27C-67064519C5D9

P698

Q36810712-E8890DB9-1701-4D74-B49C-62ECA82A2E3C

P932

Q36810712-B0EABD56-3B46-4BB6-9F6D-D6F447468E49

P356

JCO.2012.44.1238

P1433

Journal of Clinical Oncology

P1476

Elevated risk of prostate cancer among men with Lynch syndrome.

@en

P2093

Bhramar Mukherjee

http://www.w3.org/2001/XMLSchema#string

Elena M Stoffel

http://www.w3.org/2001/XMLSchema#string

Fay Kastrinos

http://www.w3.org/2001/XMLSchema#string

Fei Wang

http://www.w3.org/2001/XMLSchema#string

Kathleen A Cooney

http://www.w3.org/2001/XMLSchema#string

Sapna Syngal

http://www.w3.org/2001/XMLSchema#string

Shu-Chen Huang

http://www.w3.org/2001/XMLSchema#string

Stephen B Gruber

http://www.w3.org/2001/XMLSchema#string

Victoria M Raymond

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds

Germline mutations in HOXB13 and prostate-cancer risk

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Risk of pancreatic cancer in families with Lynch syndrome.

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.

Cancer risk in mutation carriers of DNA-mismatch-repair genes.

Cancer Incidence in BRCA1 mutation carriers.

Microsatellite instability in colorectal cancer-the stable evidence.

P304

1713-1718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2012.44.1238

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236081786

http://www.w3.org/2001/XMLSchema#string

P698

23530095

http://www.w3.org/2001/XMLSchema#string

P932

3641694

http://www.w3.org/2001/XMLSchema#string